Merck & Co. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec.... Show more
Segments: Pharmaceutical; Animal Health; Healthcare Services; Alliances

Symbol: MRK
Exchange: NYSE
Sector: Healthcare

Merck Financial Health

Profitability:8.61/10

Merck has better Profitability than 72.73% of the companies on the Drug Manufacturers industry

Net Margin: 20.26%

Merck has better Net Margin than 60% of the companies on the Drug Manufacturers industry


ROE (Return on Equity): 8.57%

Merck has better ROE (Return on Equity) than 77.78% of the companies on the Drug Manufacturers industry


ROA (Return on Assets): 2.8%

Merck has better ROA (Return on Assets) than 77.78% of the companies on the Drug Manufacturers industry


Operating Efficiency:9.96/10

Merck has better Operating Efficiency than 80% of the companies on the Drug Manufacturers industry

Operating Margin: 106.82%

Merck has better Operating Margin than 80% of the companies on the Drug Manufacturers industry


Liquidity:4.52/10

Merck has worst Liquidity than 50% of the companies on the Drug Manufacturers industry

Quick Ratio: 0.98

Merck has worst Quick Ratio than 58.33% of the companies on the Drug Manufacturers industry


Operating Cash Flow Ratio: 0.59

Merck has better Operating Cash Flow Ratio than 55.56% of the companies on the Drug Manufacturers industry


Solvency:5.76/10

Merck has worst Solvency than 50% of the companies on the Drug Manufacturers industry

Debt to Equity Ratio: 0.97

Merck has worst Debt to Equity Ratio than 55.56% of the companies on the Drug Manufacturers industry


Interest Coverage Ratio: 0.59

Merck has better Interest Coverage Ratio than 55.56% of the companies on the Drug Manufacturers industry


Merck revenue by location
Merck revenue by segment
Merck revenue quarter by quarter
Merck operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more